中肠和胰腺起源的恶性神经内分泌肿瘤的生存情况比较。
Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin.
作者信息
Johanson V, Tisell L E, Olbe L, Wängberg B, Nilsson O, Ahlman H
机构信息
Department of Surgery, Sahlgrenska University Hospital, Göteborg University, Sweden.
出版信息
Br J Cancer. 1999 Jun;80(8):1259-61. doi: 10.1038/sj.bjc.6690494.
Abstract
The survival of 64 consecutive patients with disseminated midgut carcinoid tumours was compared in a retrospective study with that of 25 consecutive patients with sporadic malignant endocrine pancreatic tumours treated according to similar surgical principles. The presence of hepatic metastases implied a worse prognosis in neuroendocrine tumours of pancreatic rather than midgut origin. This infers that these tumour types must be separated when treatments are evaluated.
摘要
在一项回顾性研究中，对64例连续性播散性中肠类癌肿瘤患者的生存率与25例连续性散发性恶性内分泌胰腺肿瘤患者（根据相似的手术原则进行治疗）的生存率进行了比较。肝转移的存在意味着胰腺而非中肠起源的神经内分泌肿瘤预后更差。这表明在评估治疗方法时，必须将这些肿瘤类型区分开来。
相似文献
1
Comparison of survival between malignant neuroendocrine tumours of midgut and pancreatic origin.中肠和胰腺起源的恶性神经内分泌肿瘤的生存情况比较。
Br J Cancer. 1999 Jun;80(8):1259-61. doi: 10.1038/sj.bjc.6690494.
2
Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.中肠类癌肿瘤患者描述：来自丹麦一个中心的临床数据库
In Vivo. 2007 Jul-Aug;21(4):679-84.
3
Classification of low-grade neuroendocrine tumors of midgut and unknown origin.中肠及起源不明的低级别神经内分泌肿瘤的分类
Hum Pathol. 2002 Nov;33(11):1126-32. doi: 10.1053/hupa.2002.129204.
4
Midgut carcinoid tumours: surgical treatment and prognosis.中肠类癌肿瘤：手术治疗与预后
Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):717-28. doi: 10.1016/j.bpg.2005.05.005.
5
Prolonged survival after hepatic artery embolization in patients with midgut carcinoid syndrome.中肠类癌综合征患者肝动脉栓塞术后的长期生存
Br J Surg. 2009 May;96(5):517-21. doi: 10.1002/bjs.6587.
6
Surgery on neuroendocrine tumours.神经内分泌肿瘤手术
Best Pract Res Clin Endocrinol Metab. 2007 Mar;21(1):87-109. doi: 10.1016/j.beem.2006.12.004.
7
Malignancy-associated allelic losses on the X-chromosome in foregut but not in midgut endocrine tumours.前肠而非中肠内分泌肿瘤中X染色体上与恶性肿瘤相关的等位基因缺失。
J Pathol. 2002 Apr;196(4):401-7. doi: 10.1002/path.1075.
8
Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours.胃肠道内分泌肿瘤。转移性内分泌肿瘤治疗中的移植。
Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):637-48. doi: 10.1016/j.bpg.2005.03.008.
9
Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours.胃肠道内分泌肿瘤肝转移的化疗栓塞及其他消融治疗
Best Pract Res Clin Gastroenterol. 2005 Aug;19(4):585-94. doi: 10.1016/j.bpg.2005.02.011.
10
Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).中肠肿瘤（空肠、回肠和升结肠，包括类癌综合征）。
Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):705-15. doi: 10.1016/j.bpg.2005.05.007.
引用本文的文献
1
Establishing the Quantitative Relationship Between Lanreotide Autogel®, Chromogranin A, and Progression-Free Survival in Patients with Nonfunctioning Gastroenteropancreatic Neuroendocrine Tumors.建立兰瑞肽长效注射凝胶、嗜铬粒蛋白A与无功能性胃肠胰神经内分泌肿瘤患者无进展生存期之间的定量关系。
AAPS J. 2016 May;18(3):703-12. doi: 10.1208/s12248-016-9884-3. Epub 2016 Feb 23.
2
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors.不可切除转移性高分化胰腺神经内分泌肿瘤全身治疗的适宜性
World J Gastroenterol. 2015 Feb 28;21(8):2450-9. doi: 10.3748/wjg.v21.i8.2450.
3
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs).胃肠胰神经内分泌（包括类癌）肿瘤（NETs）管理指南。
Gut. 2012 Jan;61(1):6-32. doi: 10.1136/gutjnl-2011-300831. Epub 2011 Nov 3.
4
Biological characteristics and treatment outcomes of metastatic or recurrent neuroendocrine tumors: tumor grade and metastatic site are important for treatment strategy.转移性或复发性神经内分泌肿瘤的生物学特征和治疗结果：肿瘤分级和转移部位对治疗策略很重要。
BMC Cancer. 2010 Aug 23;10:448. doi: 10.1186/1471-2407-10-448.
5
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.胃肠胰神经内分泌（包括类癌）肿瘤管理指南
Gut. 2005 Jun;54 Suppl 4(Suppl 4):iv1-16. doi: 10.1136/gut.2004.053314.
本文引用的文献
1
Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report.肝移植治疗转移性神经内分泌肿瘤的结果。一份31例的法国多中心报告。
Ann Surg. 1997 Apr;225(4):355-64. doi: 10.1097/00000658-199704000-00003.
2
Liver transplantation for metastatic neuroendocrine tumors.转移性神经内分泌肿瘤的肝移植
Ann Surg. 1997 Apr;225(4):347-54. doi: 10.1097/00000658-199704000-00002.
3
Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation.转移性内分泌肿瘤：药物治疗、手术切除还是肝移植。
World J Surg. 1996 Sep;20(7):908-14; discussion 914-5. doi: 10.1007/s002689900138.
4
Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction.积极肿瘤减瘤术后播散性中肠类癌肿瘤患者的生存情况
World J Surg. 1996 Sep;20(7):892-9; discussion 899. doi: 10.1007/s002689900136.
5
Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.生长抑素类似物奥曲肽与转移性内分泌胃肠胰腺肿瘤的肿瘤生长抑制
Gut. 1996 Mar;38(3):430-8. doi: 10.1136/gut.38.3.430.
6
The management of patients with advanced carcinoid tumors and islet cell carcinomas.
Ann Intern Med. 1994 Feb 15;120(4):302-9. doi: 10.7326/0003-4819-120-4-199402150-00008.
7
Hepatic resection for metastatic neuroendocrine carcinomas.转移性神经内分泌癌的肝切除术
Am J Surg. 1995 Jan;169(1):36-42; discussion 42-3. doi: 10.1016/s0002-9610(99)80107-x.
8
Surgical management of carcinoid tumors: role of debulking and surgery for patients with advanced disease.类癌肿瘤的外科治疗：减瘤手术及晚期疾病患者手术的作用
Digestion. 1994;55 Suppl 3:98-103. doi: 10.1159/000201209.
9
Liver Metastases.肝转移
Curr Probl Surg. 1981 Mar;18(3):157-202. doi: 10.1016/s0011-3840(81)80009-3.
10
Neuroendocrine carcinomas of the gastrointestinal tract.胃肠道神经内分泌癌
Semin Diagn Pathol. 1984 Feb;1(1):13-8.
Zotero 插件